Free Trial

Smith & Nephew (SNN) Stock Price, News & Analysis

-0.04 (-0.14%)
(As of 07/18/2024 ET)
Today's Range
50-Day Range
52-Week Range
1.59 million shs
Average Volume
964,556 shs
Market Capitalization
$12.33 billion
P/E Ratio
Dividend Yield
Price Target

Smith & Nephew MarketRank™ Stock Analysis

Analyst Rating
Short Interest
1.15% of Float Sold Short
Dividend Strength
Based on Four Factors
News Sentiment
0.89mentions of Smith & Nephew in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From $1.70 to $2.09 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.27 out of 5 stars

Medical Sector

764th out of 915 stocks

Surgical Appliances & Supplies Industry

17th out of 18 stocks

SNN stock logo

About Smith & Nephew Stock (NYSE:SNN)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

SNN Stock Price History

SNN Stock News Headlines

Kiss of death from Joe Biden
I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.
Kiss of death from Joe Biden
I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.
See More Headlines
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Ex-Dividend for 5/22 Dividend
Dividend Payable
Fiscal Year End

Industry, Sector and Symbol

Surgical appliances & supplies
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
$5.55 billion
Cash Flow
$3.32 per share
Book Value
$11.94 per share


Free Float
Market Cap
$12.52 billion

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Deepak S. Nath Ph.D. (Age 52)
    CEO & Director
    Comp: $4.66M
  • Mr. John Terence Rogers (Age 55)
    CFO & Executive Director
  • Mr. Paul Connolly (Age 56)
    President of Global Operations
  • Mr. Andrew Swift
    Vice President of Investor Relations
  • Ms. Helen Barraclough (Age 45)
    Group General Counsel & Company Secretary
  • Ms. Alison Parkes (Age 52)
    Chief Compliance Officer & Compliance APAC
  • Mr. Joe Metzger
    Senior Vice President of Marketing Services & Communications
  • Mr. Philip G. Cowdy (Age 57)
    Chief Corporate Development & Corporate Affairs Officer
  • Ms. Elga Lohler (Age 56)
    Chief Human Resources Officer
  • Dr. Vasant Padmanabhan Ph.D. (Age 57)
    President of Research & Development and Ear, Nose & Throat

SNN Stock Analysis - Frequently Asked Questions

How have SNN shares performed this year?

Smith & Nephew's stock was trading at $27.28 on January 1st, 2024. Since then, SNN stock has increased by 3.7% and is now trading at $28.30.
View the best growth stocks for 2024 here

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) announced its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.59.

Who are Smith & Nephew's major shareholders?

Smith & Nephew's top institutional shareholders include Lorne Steinberg Wealth Management Inc. (0.05%), Clean Yield Group (0.05%), QRG Capital Management Inc. (0.02%) and Curbstone Financial Management Corp.

How do I buy shares of Smith & Nephew?

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ) and Pfizer (PFE).

This page (NYSE:SNN) was last updated on 7/18/2024 by Staff

From Our Partners